FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

330418005: Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 3 milligram/1 milliliter conventional release eye drops (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
3692996010 Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL eye drops en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) IPS terminology module (core metadata concept)
3692997018 Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 3 milligram/1 milliliter conventional release eye drops (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL eye drops Is a Medicinal product (product) true Inferred relationship Some
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL eye drops Has manufactured dose form Eye drops true Inferred relationship Some
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL eye drops Has basis of strength substance (attribute) Ciprofloxacin (substance) true Inferred relationship Some 1
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL eye drops Has concentration strength denominator unit mL true Inferred relationship Some 1
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL eye drops Has concentration strength numerator unit mg true Inferred relationship Some 1
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL eye drops Has precise active ingredient Ciprofloxacin hydrochloride true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

International Patient Summary

GB English

US English

Back to Start